| HTTP://PATHWAYCOMMONS.ORG/P... | rdf:type | biopax3:Evidence | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:comment | Cancer - Interactions investigated in the context of cancer dataset MI:0875 | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:comment | Cancer Cell (1535-6108) journal MI:0885 | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:comment | 2010 publication year MI:0886 | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:comment | Cancer - Interactions investigated in the context of cancer data-processing MI:0633 | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:comment | rac1@cornell.edu contact-email MI:0634 | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:comment | Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:comment | Wang JB., Erickson JW., Fuji R., Ramachandran S., Gao P., Dinavahi R., Wilson KF., Ambrosio AL., Dias SM., Dang CV., Cerione RA. author-list MI:0636 | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:comment | NIH 3T3 cells used stably expressed the constitutively active Cdc42(F28L) mutation. exp-modification MI:0627 | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:xref | HTTP://PATHWAYCOMMONS.ORG/P... | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:xref | HTTP://PATHWAYCOMMONS.ORG/P... | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:experimentalForm | HTTP://PATHWAYCOMMONS.ORG/P... | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:experimentalForm | HTTP://PATHWAYCOMMONS.ORG/P... | lld:intact |
| HTTP://PATHWAYCOMMONS.ORG/P... | biopax3:evidence | HTTP://PATHWAYCOMMONS.ORG/P... | lld:intact |
